Biomarker Test Industry: Future Demand, Market Analysis & Outlook to 2022

Market Research Future adds new report of “Biomarker Test Market Research Report- Global Forecast to 2022” it contains Company information, geographical data and Table of Content

Competitive Analysis:

Some of the key players in this market are:

  • Hoffmann-La Roche AG
  • Novartis AG
  • GlaxoSmithKline plc.
  • GE Healthcare
  • Medtronics
  • Quest Diagnostics

Get a Sample Report @

Market Segments:

Global Biomarker test Market has been segmented

  • On the basis of Application which comprises of Cancer, Cardiovascular, Infectious Diseases, Central Nervous System
  • On the basis of End Users which includes Pharma & Biotech Companies, Diagnostic tool companies, Healthcare IT/Big data companies, Clinical laboratories.

Key Finding

  • The global Biomarker test market and is expected to reach USD 16,112.8 million by 2022.
  • On the basis of application, cancer holds the largest market share of global Biomarker test market and is expected to reach USD 5,395.6 million by 2022.
  • By end users, Pharma & Biotech companies holds the largest market share of global Biomarker test market is expected to reach USD 5,451.8 million by 2022.

Market Highlight:

The Biomarker Test Market is growing with the rapid pace; mainly due to the increasing prevalence of infectious diseases and emergence of advanced technology in the Biomarker industry. According to a recent study report published by the Market Research Future, The Global market of Biomarker Test is booming and expected to gain prominence over the forecast period. The Biomarker Test market is projected to raise up to USD 16,112.8 Million by end of 2022, at a staggering double digit CAGR of 14.5 % between 2016 and 2022.

The Global Biomarker Test Market is predominantly driven by the increasing demand from geriatric populace especially for diagnosis and treatment of diseases associated with the old age. Additionally, higher adoption rate of biomarkers technologies is also driving the growth of biomarkers market globally. Moreover, factors such as increasing research and development transpired in to field of Biomarker Test, increasing number of contract research organizations and cost effective conducting clinical trials are providing impetus to the market growth of the market. Increasing awareness of companion diagnostics and increasing demand of personalized medicine are contributing to the market growth up to a large extent.

On the other hand, ethical and regulatory issues, and early and accurate diagnosis for fatal diseases are some of the restraining factors likely to affect the market growth adversely, Government grants and initiatives for research and development of biomarkers are some of the trends for global biomarkers market.

The predominant types of biomarkers include prognostic, predictive, pharmacodynamics and efficacy response biomarker. Simultaneously, various biomarkers are available for biological systems such as immune system, cardiovascular system and metabolic system. Biomarkers are used to detect, predict disease susceptibility and monitor disease progression for infectious diseases, cancer, metabolic diseases, central nervous system disease and autoimmune diseases. Biomarker technologies have its applications in diagnosis and prognostic treatment for exposure of harmful chemicals, drug formulation and development and increasing implementation in disease diagnosis. Many drugs fail in clinical trials due to metabolism, toxicity, absorption, etc. Biomarkers are special tools usually used in clinical studies to determine the effects and desired results of drug in early stages of development. Biomarkers are cost effective and reliable for developing, monitoring and predicting efficiency of drugs.

Most healthcare professionals use diagnosis tests to clarify and support their clinical decision making. Progressively over recent years, the analytic procedure has turned out to be stronger by the need to preselect patients in light of medications and licenses. This move has come to through various factors, which incorporate propelling technology (empowering professionals to measure more particular markers of adequacy), an increased comprehension of the disease procedure, and a more prominent energy about the uniqueness of an individual’s tumour at the molecular level. These components are reflected in the changing outline of clinical trials. But this move is driven by societal elements as well as, most noticeable among which is the need to limit targeted therapies to those patients destined to benefit. With the appearance of customized/precision prescription, the one-estimate fits-all approach is being consigned to history of life science.

Intended Audience

  • Biomarker test device Manufacturer
  • Biomarker test device Vendors
  • Private Research Laboratories
  • Pharmaceutical & Biotechnology Companies
  • Market Research and Consulting Service Providers
  • Medical Research Laboratories

Browse Report Details @

Regional Analysis of Global Biomarker Test Market:

The global market for Biomarker test is growing rapidly. The market for Biomarker test is growing with the CAGR of 14.5% during the forecast period from 2016-2022. North America accounts for largest market share in 2015 and is expected to reach USD 6,640.4 million by 2022.

Asia-Pacific region is the fastest growing market for Biomarker test, which is expected to grow at a CAGR of 15.2% during the forecast period from 2016 to 2022.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.


Akash Anand,

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312



%d bloggers like this: